Michelle Gonzalez
Medical · East Boston, MANPI 1588373203
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 12.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,869 and has fallen 67.4% since, to $609 in 2025. Among medical clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 143 payments — averaging $18.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$343
- AstraZeneca$302
- Tolmar, Inc.$290
- AbbVie$246
- Merck$227
- Exact Sciences$212
- plus $1K from 16 others
What the payments were for
- Food & beverage$2,707100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 21 | $343 |
| AstraZeneca(2 entities) | 14 | $302 |
| Tolmar, Inc. | 19 | $290 |
| AbbVie | 18 | $246 |
| Merck | 12 | $227 |
| Exact Sciences | 8 | $212 |
| Novo Nordisk | 13 | $198 |
| Lilly USA, LLC | 10 | $166 |
| Otsuka America Pharmaceutical, Inc. | 5 | $119 |
| Neuraxis, Inc. | 1 | $112 |
| Johnson & Johnson | 3 | $84 |
| Boehringer Ingelheim | 3 | $61 |
| Antares Pharma, Inc. | 2 | $55 |
| Halozyme Inc | 2 | $52 |
| GSK | 2 | $51 |
| E.r. Squibb & Sons, L.L.C. | 2 | $47 |
| Seqirus USA Inc | 2 | $38 |
| Paratek Pharmaceuticals, Inc. | 2 | $33 |
| Idorsia Pharmaceuticals US Inc | 1 | $22 |
| Medtronic | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $14 |
How this compares
$2,707 in reported general payments places this provider in the 90th percentile of 421 medical providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 88 | $76,200 |
| JardianceEmpagliflozin | 77 | $69,842 |
| MounjaroTirzepatide | 38 | $47,665 |
| OzempicSemaglutide | 24 | $32,329 |
| XareltoRivaroxaban | 33 | $27,991 |
| OxycontinOxycodone Hcl | 13 | $13,783 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $13,332 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $12,440 |
| TrulicityDulaglutide | 11 | $11,347 |
| Atorvastatin Calcium | 458 | $6,691 |
| Potassium Chloride | 31 | $4,799 |
| Advair HfaFluticasone Propion/Salmeterol | 11 | $3,319 |
| Lisinopril | 319 | $3,121 |
| Metoprolol Succinate | 107 | $2,877 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 113 | $2,296 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Paxlovid | $343 | $77,568108 claims |
| Boehringer IngelheimJardiance | $61 | $69,84277 claims |
| Lilly USA, LLCMounjaro, Trulicity | $166 | $59,01149 claims |
| Novo NordiskOzempic | $198 | $32,32924 claims |
| Johnson & JohnsonXarelto | $84 | $27,99133 claims |
| AstraZenecaBreztri Aerosphere | $302 | $13,33212 claims |
| GSKTrelegy Ellipta | $51 | $12,44013 claims |
| AbbVieSynthroid | $246 | $1,13612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 421 medical providers in Massachusetts.
Other medical in East Boston
- Eileen CheeverLeominster$389K
- Vidal PrimiterioLawrence$22K
- Michelle BaytarianJamaica Plain$17K
- Julia FioreAgawam$16K
- Jennifer LevesqueFall River$15K
- Ashley HoffmanWestfield$13K
- Theresa FukudaBoston$13K
- Christina MessingerPlymouth$11K
- Lauren CarraSpringfield$9K
- Raul AliceaSpringfield$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.